Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Andreu

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Therapeutic Drug Monitoring|December 16, 1998
Therapeutic drug monitoring of tacrolimus in liver transplantation, phase III FK506 multicenter Spanish Study Group: a two-year follow-upL Pou, M Brunet, I Bilbao, et al.
Journal of Hepatology|March 26, 1998
Liver transplantation in patients with non-biliary cirrhosis: prognostic value of preoperative factorsE González, A Rimola, M Navasa, et al.
Hepatology (Baltimore, Md.)|October 1, 1992
S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injuryF Corrales, A Giménez, L Alvarez, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantationC Margarit, A Rimola, I Gonzalez-Pinto, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Liver transplantation in patients with Caroli's disease and recurrent cholangitisM Sans, A Rimola, M Navasa, et al.
Transplantation|March 27, 1996
Rhodococcus equi infection after liver transplantationL Sabater, H Andreu, J C García-Valdecasas, et al.
Journal of Hepatology|July 1, 1996
Diabetes mellitus after liver transplantation: prevalence and predictive factorsM Navasa, J Bustamante, C Marroni, et al.
Journal of Hepatology|August 1, 1996
Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantationM Navasa, X Forns, V Sánchez, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Therapeutic Drug Monitoring|December 16, 1998
Therapeutic drug monitoring of tacrolimus in liver transplantation, phase III FK506 multicenter Spanish Study Group: a two-year follow-upL Pou, M Brunet, I Bilbao, et al.
Journal of Hepatology|March 26, 1998
Liver transplantation in patients with non-biliary cirrhosis: prognostic value of preoperative factorsE González, A Rimola, M Navasa, et al.
Hepatology (Baltimore, Md.)|October 1, 1992
S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injuryF Corrales, A Giménez, L Alvarez, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantationC Margarit, A Rimola, I Gonzalez-Pinto, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Liver transplantation in patients with Caroli's disease and recurrent cholangitisM Sans, A Rimola, M Navasa, et al.
Transplantation|March 27, 1996
Rhodococcus equi infection after liver transplantationL Sabater, H Andreu, J C García-Valdecasas, et al.
Journal of Hepatology|July 1, 1996
Diabetes mellitus after liver transplantation: prevalence and predictive factorsM Navasa, J Bustamante, C Marroni, et al.
Journal of Hepatology|August 1, 1996
Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantationM Navasa, X Forns, V Sánchez, et al.
Pageof 2